Akkaraju Srinivas

Kalaris Therapeutics Inc ยท Director

Akkaraju Srinivas is listed in public filings as director. This Akkaraju Srinivas insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Kalaris Therapeutics Inc (KLRS), Mineralys Therapeutics, Inc. (MLYS), Alumis Inc. Common Stock (ALMS), Scholar Rock Holding Corporation (SRRK), and vTv Therapeutics Inc. (VTVT). Investors use Akkaraju Srinivas's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Kalaris Therapeutics IncKLRS$42k9k sharesGrant / ExerciseJun 3, 2026$42.5K9k shares$4.72--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Kalaris Therapeutics IncKLRS$11M2.2M sharesBuyMay 20, 2026$1.2M244.3k shares$4.83--
Kalaris Therapeutics IncKLRS--14.9k sharesOtherMay 20, 2026Disclosure amount unavailable14.9k shares----
Kalaris Therapeutics IncKLRS--19.4k sharesOtherMay 20, 2026Disclosure amount unavailable4.5k shares----
Kalaris Therapeutics IncKLRS--10.7M sharesOtherMay 20, 2026Disclosure amount unavailable66.9k shares----
Mineralys Therapeutics, Inc.MLYS$233k8.3k sharesGrant / ExerciseFeb 19, 2026$232.9K8.3k shares$28.06--
Mineralys Therapeutics, Inc.MLYS--6.2k sharesGrant / ExerciseFeb 19, 2026Disclosure amount unavailable6.2k shares----
Alumis Inc. Common StockALMS$32M1.9M sharesBuyJan 9, 2026$10.0M588.2k shares$17.00--
Kalaris Therapeutics IncKLRS$15M1.5M sharesGrant / ExerciseDec 22, 2025$15.0M1.5M shares$10.00--
Kalaris Therapeutics IncKLRS$21M2M sharesBuyDec 18, 2025$5.0M479.8k shares$10.42--
Scholar Rock Holding CorporationSRRK$01.1M sharesOtherDec 12, 2025$7.8M1.1M shares$7.35--
Alumis Inc. Common StockALMS$12M1.2M sharesBuyDec 5, 2025$701.0K70k shares$10.01--
Alumis Inc. Common StockALMS$10M1.1M sharesBuyDec 5, 2025$581.5K65k shares$8.95--
Alumis Inc. Common StockALMS$14M1.3M sharesBuyDec 5, 2025$551.3K51.4k shares$10.73--
Alumis Inc. Common StockALMS$8.8M1.1M sharesBuyDec 4, 2025$540.1K66k shares$8.18--
Alumis Inc. Common StockALMS$7.8M1M sharesBuyDec 3, 2025$775.0K100k shares$7.75--
Alumis Inc. Common StockALMS$6.9M912.8k sharesBuyDec 2, 2025$724.8K96k shares$7.55--
Alumis Inc. Common StockALMS$6.1M816.8k sharesBuyDec 1, 2025$644.2K86.4k shares$7.46--
Alumis Inc. Common StockALMS$5.6M730.5k sharesBuyNov 28, 2025$295.7K38.7k shares$7.64--
Alumis Inc. Common StockALMS$5.3M691.8k sharesBuyNov 26, 2025$370.8K48.5k shares$7.64--
Alumis Inc. Common StockALMS$4.6M643.3k sharesBuyNov 20, 2025$905.4K125.7k shares$7.20--
Alumis Inc. Common StockALMS$3.4M517.5k sharesBuyNov 19, 2025$903.8K137.8k shares$6.56--
Alumis Inc. Common StockALMS$2.3M379.7k sharesBuyNov 18, 2025$621.0K102.7k shares$6.05--
Alumis Inc. Common StockALMS$1.5M277.1k sharesBuyNov 17, 2025$5.0K914 shares$5.51--
Alumis Inc. Common StockALMS$1.4M276.2k sharesBuyNov 13, 2025$1.4M276.2k shares$5.25--
Scholar Rock Holding CorporationSRRK$20M513.2k sharesBuyOct 7, 2025$503.0K12.8k shares$39.31--
Scholar Rock Holding CorporationSRRK$21M525.6k sharesBuyOct 7, 2025$498.2K12.4k shares$40.18--
Scholar Rock Holding CorporationSRRK$22M530k sharesBuyOct 7, 2025$180.4K4.4k shares$40.97--
Scholar Rock Holding CorporationSRRK$19M486.7k sharesBuyOct 6, 2025$3.1M80.9k shares$38.68--
Scholar Rock Holding CorporationSRRK$15M405.8k sharesBuyOct 6, 2025$697.7K18.4k shares$37.89--
Scholar Rock Holding CorporationSRRK$20M500.4k sharesBuyOct 6, 2025$543.3K13.7k shares$39.52--
Scholar Rock Holding CorporationSRRK$14M387.4k sharesBuyOct 3, 2025$12.0M319.7k shares$37.42--
Scholar Rock Holding CorporationSRRK$2.5M67.7k sharesBuyOct 3, 2025$2.1M56.7k shares$36.74--
Scholar Rock Holding CorporationSRRK$392k11k sharesBuyOct 3, 2025$392.1K11k shares$35.61--
vTv Therapeutics Inc.VTVT$22M983.2k sharesGrant / ExerciseSep 22, 2025$22.3M983.2k shares$22.71--
vTv Therapeutics Inc.VTVT$1.6M106k sharesGrant / ExerciseSep 22, 2025$1.6M106k shares$15.27--
vTv Therapeutics Inc.VTVT$8.8k877.2k sharesGrant / ExerciseSep 22, 2025$8.8K877.2k shares$0.01--
Mineralys Therapeutics, Inc.MLYS$15M588.2k sharesBuySep 4, 2025$15.0M588.2k shares$25.50--
vTv Therapeutics Inc.VTVT$15M655.5k sharesGrant / ExerciseSep 3, 2025$14.9M655.5k shares$22.71--
vTv Therapeutics Inc.VTVT$15k1.5M sharesGrant / ExerciseSep 3, 2025$6.6K655.5k shares$0.01--
Alumis Inc. Common StockALMS$204k49.8k sharesGrant / ExerciseJul 30, 2025$204.2K49.8k shares$4.10--
vTv Therapeutics Inc.VTVT$182k11k sharesGrant / ExerciseJun 10, 2025$66.4K4k shares$16.59--
Scholar Rock Holding CorporationSRRK$280k9.2k sharesGrant / ExerciseMay 22, 2025$280.4K9.2k shares$30.46--
Scholar Rock Holding CorporationSRRK--21.1k sharesGrant / ExerciseMay 22, 2025Disclosure amount unavailable7.6k shares----
Alumis Inc. Common StockALMS--4.8M sharesGrant / ExerciseMay 21, 2025Disclosure amount unavailable1.2M shares----
Alumis Inc. Common StockALMS$16M3.6M sharesBuyMay 5, 2025$633.7K138.4k shares$4.58--
Alumis Inc. Common StockALMS$19M3.6M sharesBuyMay 5, 2025$116.0K22k shares$5.27--
Alumis Inc. Common StockALMS$16M3.4M sharesBuyMay 2, 2025$727.6K159.9k shares$4.55--
Kalaris Therapeutics IncKLRS$132k18k sharesGrant / ExerciseApr 10, 2025$131.6K18k shares$7.31--
Kalaris Therapeutics IncKLRS--11.4M sharesGrant / ExerciseMar 18, 2025Disclosure amount unavailable11.4M shares----
Mineralys Therapeutics, Inc.MLYS$77M5.7M sharesBuyMar 13, 2025$8.1M600k shares$13.50--
Mineralys Therapeutics, Inc.MLYS$336k32.9k sharesGrant / ExerciseFeb 13, 2025$335.6K32.9k shares$10.20--
Scholar Rock Holding CorporationSRRK$173M5.8M sharesSellOct 7, 2024$15.3M510k shares$30.00--
Scholar Rock Holding CorporationSRRK$173M6.3M sharesSellOct 7, 2024$14.0M510k shares$27.50--
Scholar Rock Holding CorporationSRRK$182M5.6M sharesSellOct 7, 2024$5.1M155.7k shares$32.50--
Syros Pharmaceuticals, Inc.SYRS--2.7k sharesGrant / ExerciseSep 16, 2024Disclosure amount unavailable2.7k shares----
Scholar Rock Holding CorporationSRRK--13.5k sharesGrant / ExerciseJun 27, 2024Disclosure amount unavailable13.5k shares----
Scholar Rock Holding CorporationSRRK$150k18k sharesGrant / ExerciseJun 27, 2024$150.5K18k shares$8.36--
vTv Therapeutics Inc.VTVT$103k6k sharesGrant / ExerciseJun 25, 2024$38.7K2.3k shares$17.22--
vTv Therapeutics Inc.VTVT$120k7k sharesGrant / ExerciseJun 25, 2024$16.9K983 shares$17.22--